Show simple item record

Sofosbuvir plus Peginterferon/Ribavirin for 12 weeks vs. Sofosbuvir plus Ribavirin for 16 or 24 weeks in genotype 3 HCV infected patients and treatment-experienced cirrhotic patients with genotype 2 HCV: the BOSON study

dc.contributor.authorPianko, Sen_US
dc.contributor.authorCooper, Cen_US
dc.contributor.authorBrown, Aen_US
dc.contributor.authorForton, Den_US
dc.contributor.authorNahass, Ren_US
dc.contributor.authorGeorge, Jen_US
dc.contributor.authorBarnes, Een_US
dc.contributor.authorBrainard, Den_US
dc.contributor.authorMassetto, Ben_US
dc.contributor.authorLin, Men_US
dc.contributor.authorMchutchinson, Jen_US
dc.contributor.authorSubramanian, GMen_US
dc.contributor.authorAgarwal, Ken_US
dc.contributor.authorFoster, Gen_US
dc.date.accessioned2016-02-17T12:39:41Z
dc.date.issued2015-09en_US
dc.date.submitted2016-01-05T09:38:26.186Z
dc.identifier.issn0815-9319en_US
dc.identifier.other10.1053/j.gastro.2015.07.043
dc.identifier.urihttp://www.gastrojournal.org/article/S0016-5085%2815%2901069-0/abstract
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/11123
dc.description.sponsorshipGilead Sciencesen_US
dc.format.extent90 - 90en_US
dc.language.isoenen_US
dc.relation.ispartofJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGYen_US
dc.titleSofosbuvir plus Peginterferon/Ribavirin for 12 weeks vs. Sofosbuvir plus Ribavirin for 16 or 24 weeks in genotype 3 HCV infected patients and treatment-experienced cirrhotic patients with genotype 2 HCV: the BOSON studyen_US
dc.typeArticle
dc.rights.holder2015. Elsevier Inc.
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000364505900179&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume30en_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record